• Lobbying for fair reimbursement and reasonable quality reporting and regulatory requirements for ambulatory surgery centers. Lobbying for HR1453and S2071, "The ASC Quality and Access Act of 2105"

Duration: January 1, 2009 to present

General Issues: Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Insurance, Science/Technology

Spending: about $2,865,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2009: U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), President of the U.S., White House Office, Centers For Disease Control & Prevention (CDC), House of Representatives, Senate, Health & Human Services, Dept of (HHS), Congressional Budget Office (CBO), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)